Hyaluronic Acid Penile Injection Before and After: By the Numbers
Introduction: Why Most “Before and After” Photos Don’t Tell the Real Story
Browse almost any clinic gallery for penile filler results and a pattern emerges: side-by-side images captioned with phrases like “natural-looking increase” or “improved width,” with no measurement attached. For a man weighing a significant personal and financial decision, that is not evidence. It is an impression.
This article starts from a different premise: photos are secondary evidence; clinical measurement is primary evidence. It compares four major data sources (a 324-patient audit, a 41-patient Restylane SubQ trial, a 103-man Brazilian series, and an American Urological Association systematic review), lays out a realistic settling timeline, and discloses complication rates that most galleries leave out.
The question every reader should be asking of any photo is simple: was it taken at peak swelling, or at the true settled result? This guide is written for the professional who evaluates decisions with data, not impulse.
The Problem With Photo-Only Before/After Galleries
Most top-ranking gallery pages, including those from Skinly Aesthetics, Moorgate Andrology, Rejuvall, GetMoreGirth, PhalloFILL, AndroFill UK, and AIVA Wellness, rely on visual captions rather than tape-measure data. Some disclose the product used (Neuramis Volume, Voluma, Restylane SubQ) and syringe counts, which helps, but they rarely pair those details with baseline-to-final measurements.
Other content overreaches: claims of “1 to 3 inches” of girth or “5 to 10 years” of longevity outpace what peer-reviewed literature supports. Even the largest case series top out at roughly 2.5 to 4 cm (about 1 to 1.5 inches).
The deeper issue is timing. Without knowing when an “after” photo was taken, a viewer cannot distinguish early swelling, mid-settling tissue, and the final stabilized result. Only one of those states represents what a patient actually keeps.
What “Before and After” Should Actually Mean in Clinical Terms
A credible before/after claim has four components:
- Baseline measurement taken before treatment
- Measurement method (tape at a defined point such as midshaft, or ultrasound)
- Time point of the “after” measurement relative to the procedure
- Penile state, flaccid or erect
Clinical papers routinely separate these variables. Gallery captions almost never do.
Flaccid vs. Erect Measurement: An Overlooked Distinction
The Restylane SubQ trial and the 324-patient audit both measured flaccid girth. Many gallery photos, however, show the erect state. The AUA’s clinical update notes that HA can enhance the diameter of both the flaccid and erect penis, but these are tracked as distinct metrics. Readers should ask any provider directly which state a given figure represents.
Why Baseline Anatomy Changes the Percentage Gain
In the Brazilian series, mean circumference rose from 10.0 ± 1.3 cm to 11.3 ± 1.3 cm. The same absolute gain means something different depending on the starting point: 1.3 cm is a 13% increase on a 10 cm baseline, but closer to 16% on an 8 cm baseline. Men with smaller baseline girth may therefore perceive a larger relative change from the same volume of filler.
This is why “results may vary” carries real meaning when tied to a documented baseline range, rather than functioning as a boilerplate disclaimer.
Hyaluronic Acid Penile Injection Before and After, By the Numbers: A Cross-Study Comparison
The table below consolidates the most cited clinical data on HA penile girth enhancement.
| Study | Sample Size | Baseline Girth | Final Girth / Gain | Follow-Up |
|---|---|---|---|---|
| Single-center audit | 324 | Not reported | Mean +2.5 cm flaccid (range 1.5-4 cm), mean 15 mL filler, 89% satisfaction | Longevity avg. 12 months (range 9-24) |
| Restylane SubQ trial | 41 | 7.48 ± 0.35 cm | 11.41 ± 0.34 cm at 1 month; 11.26 ± 0.33 cm at 18 months | 18 months |
| Brazilian case series | 103 | 10.0 ± 1.3 cm | 11.3 ± 1.3 cm (avg. +1.3 cm), mean 8.1 mL | ~22 days |
| AUA systematic review | Pooled | Varied | Avg. +2.27 ± 1.26 cm diameter at 4 weeks | Up to 18 months |
Two additional data points sharpen the picture:
- Dose-response study (155 men): about 0.633 cm per session, with a cumulative 2.952 cm average after four or more sequential sessions.
- HA vs. PLA randomized trial: HA produced a 2.27 cm average girth increase and superior 12-week sexual satisfaction scores (P=0.0004).
The takeaway is consistency: across independent studies, the realistic bracket is roughly 1.5 to 4 cm (about 0.6 to 1.5 inches) of girth gain. That range, not marketing superlatives, is what an informed patient should expect.
The Realistic Settling Timeline: What Happens Between Injection and “Final” Result
The settling timeline is the missing link between photos and data. It tells a reader when an image was likely captured relative to the true result. The framework has four stages: days 1 to 3 (swelling), weeks 2 to 3 (stabilization), month 1 (peak measurement), and months 12 to 24 (longevity curve).
Days 1–3: Initial Swelling Inflates the Numbers
Early post-procedure images often capture temporary edema that exaggerates girth. A 2026 real-practice confirmatory study published in the World Journal of Men’s Health found girth changes became statistically significant and stable by 4 weeks, implying early measurements are not the benchmark. Any photo taken within the first 72 hours should be discounted as unrepresentative.
Week 2–3: Tissue Stabilization Begins
During this window, inflammatory swelling resolves and the HA settles into the subcutaneous/subdartos fascial plane. Per Stoller Medical Group’s protocol, patients typically resume sexual activity within 7 to 10 days, and a more realistic shape emerges. Measurements here are closer to accurate but still not final.
Month 1: The Clinically Validated Peak Measurement Point
The 4-week mark is the standard clinical benchmark. The AUA’s 2.27 ± 1.26 cm figure, the Restylane SubQ trial’s 11.41 cm result, and an ultrasound-documented case showing midshaft girth rising from 12.3 cm to 13.0 cm were all recorded at this point. By contrast, the 2026 confirmatory study found length changes did not become apparent until around week 12, a nuance worth remembering when comparing girth and length claims. A credible “after” photo should be dated at or beyond four weeks.
12–24 Months: The Longevity Curve and When Results Begin to Fade
The 324-patient audit reported average HA persistence of 12 months (range 9 to 24), while Restylane SubQ results remained statistically unchanged through 18 months. HA works through direct volumization, so its effect is immediate; polylactic acid (PLA) instead stimulates collagen growth (fibroplasia) gradually, producing a different longevity curve. This is why practices recommend touch-up sessions around months 18 to 24. Maintenance, not a one-time permanent change, is the honest expectation.
Dose-Response: Why Syringe Count and Session Number Change the Final Numbers
The dose-response data is straightforward: roughly 0.633 cm per session, compounding to about 2.95 cm after four or more sessions. In practice, a single session produces a modest, natural-looking change, while a staged protocol builds toward a target girth over time.
This maps directly to cost. At Stoller Medical Group, procedures start at $7,500 and are priced per syringe, increasing with the desired result. Most men begin with a minimum of 10 syringes, and the average first procedure uses 15 syringes.
Competitor galleries comparing 5, 15, 23, and 30-syringe cases show that higher volumes produce more pronounced visual change. That change should be weighed against the higher correction rates reported at greater cumulative volumes. The practice’s staged-treatment philosophy aligns with the literature: incremental sessions reduce risk while building toward the goal.
The Complication Rates Competitors Don’t Disclose
An honest before/after analysis must include what can go wrong.
Migration and Asymmetry: The Most Common Issues
- Migration into the foreskin: 7.7% of patients in the 324-patient audit, managed with hyaluronidase.
- Asymmetry: 6.1% in the same cohort, managed with filler top-ups.
- Irregularities after multiple sessions: 12.3% in the dose-response study required correction with hyaluronidase or botulinum toxin.
These rates are real, but manageable precisely because HA is reversible.
Reversibility: HA’s Built-In Safety Margin Over Permanent Fillers
Hyaluronidase can dissolve HA gel in cases of asymmetry, migration, or vascular compromise. That option does not exist for permanent materials like silicone or PMMA. The Sexual Medicine Society of North America and the European Association of Urology have both called for avoiding permanent filler materials for penile augmentation. This reasoning is consistent with Stoller Medical Group’s decision not to offer surgical lengthening or permanent filler alternatives.
Rare but Serious Risks: What the Literature Shows
The literature documents rare severe events, including a case reported in BMC Urology of penile filler leading to cellulitis that progressed to septic shock and multi-organ failure requiring ICU care. The AUA also notes that highly cross-linked HA, used for longevity, carries elevated risk of inflammation, edema, and granuloma formation compared with less cross-linked formulations.
These outcomes are strongly tied to technique, sterility, and provider credentialing rather than to HA itself. Transparency also requires noting that no injectable filler is FDA-approved specifically for cosmetic penile enlargement. HA products such as Restylane and Juvederm Voluma are FDA-approved for other indications, and their penile use is off-label.
HA vs. Other Filler Approaches: How the Numbers Stack Up
In the HA vs. PLA randomized trial, HA delivered a 2.27 cm average girth increase and superior 12-week sexual satisfaction (P=0.0004), though appearance satisfaction at 4 weeks did not differ significantly. Because HA volumizes immediately while PLA builds collagen gradually, HA “after” photos become meaningful sooner.
A narrative review in Gels reported more than 80% of patients “highly satisfied,” with flaccid circumference gains of 3.2 to 4.5 cm using HA-based procedures. Permanent fillers may last longer, but they lack reversibility and carry a heavier risk profile, which is why HA remains the practice’s chosen material.
How to Read Any Before/After Photo Using This Data
Apply this checklist to any gallery image, including this practice’s own:
- Flaccid or erect? Know which state is shown.
- What day post-procedure? Discount anything within 72 hours as swelling-inflated.
- What was the baseline measurement? A visual comparison alone is insufficient.
- How many syringes and sessions? Results scale with dose.
- What is the follow-up interval? A 1-month photo and a 12-month photo tell different stories.
Numbers validate or invalidate what a photo appears to show.
Setting Realistic Expectations
The credible bracket is 1.5 to 4 cm (about 0.6 to 1.5 inches) of girth gain, depending on baseline anatomy, syringe volume, and session count. Cost follows the same dose-response logic: pricing starts at $7,500, is calculated per syringe, typically begins at a minimum of 10 syringes, and averages 15 syringes for a first procedure.
Expectations are best framed around a staged plan rather than a single dramatic session. A thorough consultation establishes baseline anatomy and sets a personalized, data-informed girth target.
Why Case Volume and Physician-Led Protocol Make a Before/After Reference Point More Reliable
Published cohorts range from 41 to 324 patients. Stoller Medical Group reports more than 15,000 enlargement procedures, a substantially larger experience base from which to calibrate expectations.
Treatment is led by Dr. Roy B. Stoller, a board-certified physician with 25+ years in aesthetic and restorative medicine and 5 years focused specifically on non-surgical male enhancement. This physician-led model aligns with professional society calls for credentialed, medically supervised injection. Staged treatments, hospital-grade sterility protocols, and the refusal to offer surgical lengthening or permanent fillers directly address the severe risks outlined above.
The practice’s reported outcomes (a 10-day recovery, 80 to 90% lasting improvement in girth and volume, and typical longevity of 18 to 24 months) sit within, and at the upper end of, the published benchmarks.
Conclusion: Numbers First, Photos Second
Credible before/after evidence requires measurement data, a settling timeline, and disclosed complication rates, not just a flattering image. Across independent studies, HA penile injection consistently delivers roughly 1.5 to 4 cm of girth gain. Readers now have a framework to evaluate any clinic’s claims critically, including this practice’s gallery. The logical next step is a personalized, data-grounded assessment.
Ready to See What the Numbers Show?
Stoller Medical Group offers free consultations that include a baseline measurement and a realistic projection based on individual anatomy. With 15,000+ physician-led procedures, the practice offers one of the most statistically grounded reference points available.
Consultations are available at five locations: Manhattan, Long Island, Albany, Chadds Ford (Pennsylvania), and Eagan (Minnesota).
Men ready to move from photos to data can book a consultation to discuss a staged treatment plan and transparent, per-syringe pricing starting at $7,500.
